- Led the sell-side M&A and staple financing transaction for North Castle Partners' $720 million exit of its portfolio company, CRC Health, in a dual track initial public offering and sale process.
- Completed the sale of the company to Bain Capital, resulting in 6x return on capital.
- Drafted the information memorandum and IPO prospectus; preparing the financial projections, DCF, and LBO-based valuation materials.
- Coordinated the due diligence, negotiated the SPA, and spearheaded the closing process.
- Led various sell-side transactions including Alpha Therapeutics' break-up and two-part sale to Baxter and Probitas for $100 million, LabOne’s sale to Quest Diagnostics for $1 billion, Oratec’s sale to Smith & Nephew for $300 million, and Edwards Lifesciences’ sale of its services business to Fresenius for $50 million.
- Led the buy-side M&A advisory for Guidant Corporation's $2.5 billion acquisition of Cook Group.
- Built and presented the bottoms-up financial forecast and comparables-based valuation model.
- Prepared pro forma financial impact analysis including EPS accretion/dilution and EPS growth.
- Designed and presented transaction structure alternatives and drafted the public announcement materials.
- Led the buy-side advisory on various M&A transactions including Madison Dearborn Partners’ buy-out of VWR for $4 billion, McKesson’s acquisition of Fisher Scientific for $12 billion, Bristol-Myers Squibb's acquisition of DuPont Pharmaceuticals for $7.8 billion, and EcoLab’s $73 million minority investment in KIK.
- Led the $779 million public equity raise for King Pharmaceuticals.
- Drafted the offering prospectus and prepared the valuation materials to establish the offering price.
- Presented the investment merits and risks to the equities sales force and responded to inquiries from the SEC and investors.
- Built the equity book and oversaw its completion.
- Led various equity raise transactions including Universal American Financial's $180 million offering, Endo Pharmaceuticals' $91 million offering, and Thoratec Corporation's $112 million offering.
- Led the $2 billion acquisition debt financing for Fillmore Capital Partner’s buy-out of Genesis Healthcare and was responsible for various areas including performing the debt capacity analysis.
- Constructed the credit model and covenant stress test.
- Drafted and presented ratings advisory presentation; also prepared the credit approval presentation.
- Wrote and negotiated the financing terms sheet and the credit agreement.
- Led various debt raise transactions including the $2.6 billion financing for MDP's buyout of VWR, the $350 million financing for Bain Capital’s buyout of CRC Health, the $50 million financing for CRC Health’s acquisition of Aspen Education, the $225 million financing for Patheon, and the $345 million convertible offering for King Pharmaceuticals.
- Spearheaded and completed various strategic advisory mandates including advising the board of directors of Universal Health Services to defend against a hostile bidder, advising the board of directors of Extendicare on its strategic alternatives, building an international expansion strategy for Henry Schein.
- Structured and financed McKesson Corporation's $2 billion class-action lawsuit.
Focus areas: Mergers & Acquisitions (M&A), Corporate Finance, Strategic Investments, Minority Investments, Investment Thesis, Investor Decks, Investment Memoranda, Investment Monitoring, Investment Briefs, Value Investing, DCF Valuation, Discounted Cash Flow (DCF), M&A (Buy-side), M&A (Sell-side), Share Buybacks, Leveraged Buyout Model, Management Buyout Finance, Private Equity, Private Equity Valuation, Private Company Valuation, Project Finance, Project Evaluation, Projected Cash Flow, Comparable Company Analysis, Due Diligence, Equity Financing, Debt, Debt Raises, Debt Restructuring, Subordinated Debt, Convertible Debt, Bank Covenants, Bank Debt Raises, Acquisition Accounting, Asset-based Lending, Asset Valuation, Asset-based Finance, Commercial Mortgage-backed Securities (CMBS), Intangible Asset Valuation, M&A Earn-out Agreements, Credit Analysis, Credit Risk, Equity Raises, Equity Offerings, Equity Capital, Equity Valuation, Growth Equity, M&A Modeling, Cash Flow Modeling, Valuation Modeling, Transaction Modeling, Financial Modeling, Revenue Modeling, Debt Structuring, Capital Structure, Transaction Structuring, Finance Structures, Capital Structuring
Investor Committee Presentation
